Clinuvel Pharmaceuticals Limited - CUV.AX

CUV.AX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CUV.AX	-0.8	2.5	0.9	-11.9	-17.6	-24.2	-48.5	-54.4	231.5	295.4
S&P 500	-0.5	1.2	2.9	5.4	13.0	21.8	31.6	85.9	198.9	34104.6

Compare CUV.AX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CUV.AX
name	Clinuvel Pharmaceuticals Limited
price	12.1
changes percentage	-0.8197
change	-0.1
day low	12.01
day high	12.35
year high	17.71
year low	11.16
market cap	605734470
price avg 50	12.234
price avg 200	14.05505
exchange	ASX
volume	75587
avg volume	108538
open	12.23
previous close	12.2
eps	0.7
pe	17.29
earnings announcement	2025-02-20T05:00:00.000+0000
shares outstanding	50060700
timestamp	2025-01-31 05:10:46

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 85.3%

Overall Quarterly Financial Health: 73.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	88178308	78321318	12.59
gross profit	80445198	50589461	59.02
gross profit ratio	0.91	0.65	41.24
research and development expenses	2348296	1268456	85.13
operating expenses	31297031	9679676	223.33
interest income	7324871	3905856	87.54
interest expense	4454292	3192713	39.51
ebitda	56275596	46368129	21.37
ebitdaratio	0.64	0.53	19.87
operating income	49148167	40909780	20.14
operating income ratio	0.56	0.52	6.71
net income	35636359	30604566	16.44
net income ratio	0.4	0.39	3.42
eps	0.72	0.62	16.13

Overall Score of Annual Income Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 88 million in 2024 from 78 million in 2023 representing a change of 12.59%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 80 million in 2024 from 51 million in 2023 representing a change of 59.02%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 2 million in 2024 from 1 million in 2023 representing a change of 85.13%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 31 million in 2024 from 10 million in 2023 representing a change of 223.33%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 56 million in 2024 from 46 million in 2023 representing a change of 21.37%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 49 million in 2024 from 41 million in 2023 representing a change of 20.14%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 36 million in 2024 from 31 million in 2023 representing a change of 16.44%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.72 in 2024 from 0.72 in 2023 representing a change of 16.13%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
revenue	55376436	32256884	71.67
gross profit	50086459	16920375	196.01
gross profit ratio	0.9	0.52	72.43
research and development expenses	1595797	752499	112.07
operating expenses	15411302	5587689	175.81
interest income	3661153	3663718	-0.07
interest expense	0	0	NaN
ebitda	34848951	14473010	140.79
ebitdaratio	0.63	0.37	70.47
operating income	32218862	11332690	184.30
operating income ratio	0.58	0.35	65.61
net income	24700316	10936043	125.86
net income ratio	0.45	0.34	31.56
eps	0.49	0.22	122.73

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 55 million in 2024Q4 from 32 million in 2024Q2 representing a change of 71.67%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 50 million in 2024Q4 from 17 million in 2024Q2 representing a change of 196.01%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 15 million in 2024Q4 from 6 million in 2024Q2 representing a change of 175.81%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 35 million in 2024Q4 from 14 million in 2024Q2 representing a change of 140.79%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 32 million in 2024Q4 from 11 million in 2024Q2 representing a change of 184.3%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 25 million in 2024Q4 from 11 million in 2024Q2 representing a change of 125.86%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.49 in 2024Q4 from 0.49 in 2024Q2 representing a change of 122.73%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 2 million in 2024Q4 from 1 million in 2024Q2 representing a change of 112.07%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	231123549	194524790	18.81
total liabilities	28112183	29893647	-5.96
total equity	203011366	164631143	23.31
cash and cash equivalents	183868471	23867221	670.38
short term investments	148667720	132946316	11.83
long term investments	134208	2851187	-95.29
total current assets	222063842	189617798	17.11
total non current assets	9059707	4906992	84.63
total current liabilities	25212197	25494713	-1.11
total non current liabilities	2899986	4398934	-34.08
common stock	168802368	151849375	11.16
retained earnings	29963627	-9774276	406.56
total debt	879784	999865	-12.01

Overall Score of Annual Balance Sheet

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 231 million in 2024 from 195 million in 2023 representing a change of 18.81%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 28 million in 2024 from 30 million in 2023 representing a change of -5.96%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 203 million in 2024 from 165 million in 2023 representing a change of 23.31%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 184 million in 2024 from 24 million in 2023 representing a change of 670.38%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 149 million in 2024 from 133 million in 2023 representing a change of 11.83%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 222 million in 2024 from 190 million in 2023 representing a change of 17.11%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 25 million in 2024 from 25 million in 2023 representing a change of -1.11%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 169 in 2024 from 152 in 2023 representing a change of 11.16%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 30 million in 2024 from -10 million in 2023 representing a change of 406.56%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 1 million in 2024 from 1 million in 2023 representing a change of -12.01%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
total assets	231123549	211681346	9.18
total liabilities	28112183	33031323	-14.89
total equity	203011366	178650022	13.64
cash and cash equivalents	183868471	38817216	373.68
short term investments	148667720	135631977	9.61
long term investments	134208	-1	13420900.00
total current assets	222063842	201499153	10.21
total non current assets	9059707	10182192	-11.02
total current liabilities	25212197	29386306	-14.20
total non current liabilities	2899986	3645017	-20.44
common stock	168802368	169556603	-0.44
retained earnings	29963627	5263310	469.29
total debt	879784	1068866	-17.69

Overall Score of Quarterly Balance Sheet

0.9 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 231 million in 2024Q4 from 212 million in 2024Q2 representing a change of 9.18%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 28 million in 2024Q4 from 33 million in 2024Q2 representing a change of -14.89%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 203 million in 2024Q4 from 179 million in 2024Q2 representing a change of 13.64%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 184 million in 2024Q4 from 39 million in 2024Q2 representing a change of 373.68%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 149 million in 2024Q4 from 136 million in 2024Q2 representing a change of 9.61%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 222 million in 2024Q4 from 201 million in 2024Q2 representing a change of 10.21%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 25 million in 2024Q4 from 29 million in 2024Q2 representing a change of -14.2%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 30 million in 2024Q4 from 5 million in 2024Q2 representing a change of 469.29%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 1 million in 2024Q4 from 1 million in 2024Q2 representing a change of -17.69%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Common Stock: Common Stock decreased to 169 in 2024Q4 from 170 in 2024Q2 representing a change of -0.44%. This indicates a decrease in ownership interest.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	3307730	-3542061	193.38
operating cash flow	37053882	36912063	0.38
free cash flow	31477667	35884532	-12.28
capital expenditure	-5576215	-1027531	-442.68
depreciation and amortization	1142326	789408	44.71
deferred income tax	0	-19754332	100.00
stock based compensation	6107272	8989788	-32.06
accounts payables	-648316	4514552	-114.36
inventory	0	-7687571	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-5576215	-1027531	-442.68
net cash used for investing activites	-29033926	-1027531	-2725.60
debt repayment	0	0	NaN
common stock issued	4155010	0	NaN
common stock repurchased	-4909246	0	NaN
dividends paid	-2470227	-1976414	-24.99
net cash used provided by financing activities	-3571807	-2240132	-59.45
cash at end of period	35200751	23867221	47.49
accounts receivables	0	-6012709	100.00
cash at beginning of period	31893021	27409282	16.36

Overall Score of Annual Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 3 million in 2024 from -4 million in 2023 representing a change of 193.38%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 37 million in 2024 from 37 million in 2023 representing a change of 0.38%. This indicates that the company generated more cash from its core business operations.

  Capital Expenditure: Capital Expenditure decreased to -6 million in 2024 from -1 million in 2023 representing a change of -442.68%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 6 million in 2024 from 9 million in 2023 representing a change of -32.06%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2024 from 5 million in 2023 representing a change of -114.36%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to 31 million in 2024 from 36 million in 2023 representing a change of -12.28%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024 from -20 million in 2023 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024 from -6 million in 2023 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -2 million in 2024 from -2 million in 2023 representing a change of -24.99%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
operating cash flow	10674039	26379843	-59.54
free cash flow	10399373	21078294	-50.66
capital expenditure	-274666	-5301549	94.82
depreciation and amortization	509686	575430	-11.43
deferred income tax	0	0	NaN
stock based compensation	464198	5643074	-91.77
accounts receivables	-4023652	0	NaN
accounts payables	0	0	NaN
inventory	-1107151	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-274666	-5301549	94.82
net cash used for investing activites	-13020916	-16013010	18.69
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-4909246	0	NaN
dividends paid	0	-2470227	100.00
net cash used provided by financing activities	-937317	-2634490	64.42
net change in cash	-3616465	14949995	-124.19
cash at end of period	35200751	38817216	-9.32
cash at beginning of period	38817216	23867221	62.64

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -4 million in 2024Q4 from 15 million in 2024Q2 representing a change of -124.19%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 11 million in 2024Q4 from 26 million in 2024Q2 representing a change of -59.54%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 10 million in 2024Q4 from 21 million in 2024Q2 representing a change of -50.66%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2024Q4 from -5 million in 2024Q2 representing a change of 94.82%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q4 from 6 million in 2024Q2 representing a change of -91.77%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -4 million in 2024Q4 from 0 million in 2024Q2 representing a change of nan%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q4 from -2 million in 2024Q2 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q4 2024 Earnings call transcript
Q2 2023 Earnings call transcript
Q2 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-06-30	2023-06-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	1.77	1.59	11.63
net income per share	0.72	0.62	15.45
operating cash flow per share	0.74	0.75	-0.47
free cash flow per share	0.63	0.73	-13.03
cash per share	6.67	3.17	110.26
book value per share	4.07	3.33	22.26
tangible book value per share	4.07	3.32	22.43
shareholders equity per share	4.07	3.33	22.26
interest debt per share	0.11	0.08	26.14
market cap	760965714.45	883456843.44	-13.86
enterprise value	577977027.45	860589487.44	-32.84
pe ratio	21.35	28.87	-26.03
price to sales ratio	8.63	11.28	-23.49
pocfratio	20.54	23.93	-14.19
pfcf ratio	24.17	24.62	-1.81
pb ratio	3.75	5.37	-30.15
ptb ratio	3.75	5.37	-30.15
ev to sales	6.55	10.99	-40.35
enterprise value over ebitda	10.27	18.56	-44.66
ev to operating cash flow	15.6	23.31	-33.10
ev to free cash flow	18.36	23.98	-23.44
earnings yield	0.05	0.03	35.18
free cash flow yield	0.04	0.04	1.84
debt to equity	0.0	0.01	-28.64
debt to assets	0.0	0.01	-25.94
net debt to ebitda	-3.25	-0.49	-559.34
current ratio	8.81	7.44	18.42
interest coverage	11.03	12.81	-13.89
income quality	1.04	1.21	-13.79
dividend yield	0.0	0.0	45.10
payout ratio	0.07	0.06	7.34
sales general and administrative to revenue	0.02	0.02	16.99
research and ddevelopement to revenue	0.03	0.02	64.44
intangibles to total assets	0.0	0.0	-57.92
capex to operating cash flow	0.15	0.03	440.60
capex to revenue	0.06	0.01	382.02
capex to depreciation	4.88	1.3	275.02
stock based compensation to revenue	0.07	0.11	-39.66
graham number	8.1	6.81	18.81
roic	0.17	0.18	-6.54
return on tangible assets	0.15	0.16	-2.11
graham net net	6.61	3.0	120.18
working capital	196851645	164123085	19.94
tangible asset value	202826336	164261083	23.48
net current asset value	193951659	159724151	21.43
invested capital	204756800	167344332	22.36
average receivables	24226471.5	19208291.5	26.13
average payables	2568554	1525435.5	68.38
average inventory	10073037.5	5675676.5	77.48
days sales outstanding	108.61	103.53	4.91
days payables outstanding	110.7	36.74	201.29
days of inventory on hand	501.57	125.29	300.32
receivables turnover	3.36	3.53	-4.68
payables turnover	3.3	9.93	-66.81
inventory turnover	0.73	2.91	-75.02
roe	0.18	0.19	-5.57
capex per share	0.11	0.02	438.07

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.18 on 2024-06-30 from 0.19 on 2023-06-30, representing a change of -5.57%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 21.35 on 2024-06-30 from 28.87 on 2023-06-30, representing a change of -26.03%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 8.81 on 2024-06-30 from 7.44 on 2023-06-30, representing a change of 18.42%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-06-30 from 0.01 on 2023-06-30, representing a change of -28.64%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q4	2023-12-31 Q2	Q/Q change %
CUV.AX
calendar year	2024	2024	NaN
revenue per share	1.1	0.64	70.38
net income per share	0.49	0.22	124.16
operating cash flow per share	0.21	0.53	-59.84
free cash flow per share	0.21	0.42	-51.04
cash per share	6.58	3.48	89.18
book value per share	4.02	3.56	12.78
tangible book value per share	4.02	3.56	12.79
shareholders equity per share	4.02	3.56	12.78
interest debt per share	0.02	0.02	-18.31
market cap	771267711.57	802036320	-3.84
enterprise value	588279024.57	764287970	-23.03
pe ratio	7.81	18.33	-57.42
price to sales ratio	13.93	24.86	-43.98
pocfratio	72.26	30.4	137.66
pfcf ratio	74.16	38.05	94.91
pb ratio	3.8	4.49	-15.38
ptb ratio	3.8	4.49	-15.38
ev to sales	10.62	23.69	-55.16
enterprise value over ebitda	16.88	52.81	-68.03
ev to operating cash flow	55.11	28.97	90.23
ev to free cash flow	56.57	36.26	56.01
earnings yield	0.03	0.01	134.87
free cash flow yield	0.01	0.03	-48.69
debt to equity	0.0	0.01	-27.57
debt to assets	0.0	0.01	-24.61
net debt to ebitda	-5.25	-2.61	-101.32
current ratio	8.81	6.86	28.45
interest coverage	0	0	NaN
income quality	0.43	2.41	-82.09
dividend yield	0	0.0	-100.00
payout ratio	0	0.23	-100.00
sales general and administrative to revenue	0.02	0.02	-28.59
research and ddevelopement to revenue	0.03	0.02	23.53
intangibles to total assets	0.0	0.0	-8.41
capex to operating cash flow	0.03	0.2	-87.20
capex to revenue	0.0	0.16	-96.98
capex to depreciation	0.54	9.21	-94.15
stock based compensation to revenue	0.01	0.17	-95.21
graham number	6.65	4.18	59.00
roic	0.11	0.05	107.87
return on tangible assets	0.11	0.05	106.85
graham net net	6.52	3.14	107.57
working capital	196851645	172112847	14.37
tangible asset value	202826336	178464993	13.65
net current asset value	193951659	168467830	15.13
invested capital	204756800	180186495	13.64
average receivables	19656756	17644930.5	11.40
average payables	4413771.5	4636889.5	-4.81
average inventory	11593082	11039506.5	5.01
days sales outstanding	42.64	36.48	16.89
days payables outstanding	39.9	38.04	4.90
days of inventory on hand	180.79	73.7	145.30
receivables turnover	2.11	2.47	-14.45
payables turnover	2.26	2.37	-4.67
inventory turnover	0.5	1.22	-59.23
roe	0.12	0.06	98.76
capex per share	0.01	0.11	-94.86

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 7.81 on 2024-06-30 Q4 from 18.33 on 2023-12-31 Q2, representing a change of -57.42%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 8.81 on 2024-06-30 Q4 from 6.86 on 2023-12-31 Q2, representing a change of 28.45%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-06-30 Q4 from 0.01 on 2023-12-31 Q2, representing a change of -27.57%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 20.33 which is higher than current price 12.1, indicates the company may be undervalued.